Velarion Records
Free. Unsubscribe any time.

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 4 reporting owners, covering 38 transactions and 385,644 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Avalo Therapeutics, Inc. 38

Adoption dates in Avalo Therapeutics, Inc. 4

Results prints in Avalo Therapeutics, Inc. 0

Trades before a print in Avalo Therapeutics, Inc. 0

Interval to Avalo Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Avalo Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on November 12, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.